DONNA LORNTZ: Open Payments
NPI 1144589409 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 57 payments from 16 companies in 2025. Trend: 2023 $479 · 2024 $989 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 19 | $296 |
| Xeris Pharmaceuticals, Inc. | 4 | $87 |
| TOLMAR, INC. | 5 | $80 |
| Alexion Pharmaceuticals, Inc. | 4 | $80 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| Tandem Diabetes Care, Inc. | 6 | $70 |
| Novo Nordisk Inc | 3 | $68 |
| Lilly USA, LLC | 3 | $57 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $48 |
| Sequel Med Tech, LLC | 2 | $34 |
Products named: Korlym, RECORLEV, JATENZO, STRENSIQ, CRENESSITY, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, ISTURISA.
Industry payments across IN — which companies pay providers there.
